Skip to main content
. 2012 Oct 10;13(10):12925–12938. doi: 10.3390/ijms131012925

Figure 1.

Figure 1

Hyaluronan synthases (HAS) and hyaluronidases (HYAL) mRNA in serous ovarian carcinoma: Examples of HAS and HYAL mRNA expression in effusions, primary carcinomas and solid metastases from patients with serous ovarian carcinoma. The 28S RNA served as control. HYAL2 levels were analyzed using quantitative PCR (qPCR), but a gel was nevertheless run in addition, in order to be able to visually present all enzymes similarly.